Literature DB >> 26623693

Risk-based Heterogeneity of Treatment Effect in Trials and Implications for Surveillance of Clinical Effectiveness Using Regression Discontinuity Designs.

Allan J Walkey1, Jacob Bor2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26623693      PMCID： PMC4731705          DOI： 10.1164/rccm.201508-1533LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   30.528


× No keyword cloud information.
  4 in total

Review 1.  Regression discontinuity designs are underutilized in medicine, epidemiology, and public health: a review of current and best practice.

Authors:  Ellen Moscoe; Jacob Bor; Till Bärnighausen
Journal:  J Clin Epidemiol       Date:  2015-02       Impact factor: 6.437

2.  Three approaches to causal inference in regression discontinuity designs.

Authors:  Jacob Bor; Ellen Moscoe; Till Bärnighausen
Journal:  Epidemiology       Date:  2015-03       Impact factor: 4.822

3.  Implications of Heterogeneity of Treatment Effect for Reporting and Analysis of Randomized Trials in Critical Care.

Authors:  Theodore J Iwashyna; James F Burke; Jeremy B Sussman; Hallie C Prescott; Rodney A Hayward; Derek C Angus
Journal:  Am J Respir Crit Care Med       Date:  2015-11-01       Impact factor: 21.405

4.  Regression discontinuity designs in epidemiology: causal inference without randomized trials.

Authors:  Jacob Bor; Ellen Moscoe; Portia Mutevedzi; Marie-Louise Newell; Till Bärnighausen
Journal:  Epidemiology       Date:  2014-09       Impact factor: 4.822
  4 in total
  1 in total

Review 1.  Regression discontinuity designs in healthcare research.

Authors:  Atheendar S Venkataramani; Jacob Bor; Anupam B Jena
Journal:  BMJ       Date:  2016-03-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.